MX355416B - Biomarcadores de cancer de pulmon y usos de los mismos. - Google Patents

Biomarcadores de cancer de pulmon y usos de los mismos.

Info

Publication number
MX355416B
MX355416B MX2014004860A MX2014004860A MX355416B MX 355416 B MX355416 B MX 355416B MX 2014004860 A MX2014004860 A MX 2014004860A MX 2014004860 A MX2014004860 A MX 2014004860A MX 355416 B MX355416 B MX 355416B
Authority
MX
Mexico
Prior art keywords
lung cancer
cancer biomarkers
individual
level
nsclc
Prior art date
Application number
MX2014004860A
Other languages
English (en)
Spanish (es)
Other versions
MX2014004860A (es
Inventor
Alaric Williams Stephen
Riel-Mehan Michael
N Brody Edward
A E Stewart Alex
M Ostroff Rachel
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of MX2014004860A publication Critical patent/MX2014004860A/es
Publication of MX355416B publication Critical patent/MX355416B/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
MX2014004860A 2011-10-24 2011-10-24 Biomarcadores de cancer de pulmon y usos de los mismos. MX355416B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/057499 WO2013062515A2 (en) 2011-10-24 2011-10-24 Lung cancer biomarkers and uses thereof

Publications (2)

Publication Number Publication Date
MX2014004860A MX2014004860A (es) 2014-05-27
MX355416B true MX355416B (es) 2018-04-18

Family

ID=48168748

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014004860A MX355416B (es) 2011-10-24 2011-10-24 Biomarcadores de cancer de pulmon y usos de los mismos.

Country Status (15)

Country Link
EP (1) EP2771692B1 (enExample)
JP (1) JP5986638B2 (enExample)
KR (1) KR101921945B1 (enExample)
CN (2) CN103890586B (enExample)
AU (1) AU2011378427B8 (enExample)
BR (1) BR112014006432B8 (enExample)
CA (3) CA3064363C (enExample)
ES (1) ES2674318T3 (enExample)
IL (2) IL231426A (enExample)
IN (1) IN2014CN01787A (enExample)
MX (1) MX355416B (enExample)
NZ (1) NZ621733A (enExample)
SG (1) SG11201400375SA (enExample)
WO (1) WO2013062515A2 (enExample)
ZA (1) ZA201401476B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2801110C (en) 2010-07-09 2021-10-05 Somalogic, Inc. Lung cancer biomarkers and uses thereof
WO2014179959A1 (en) * 2013-05-09 2014-11-13 The Procter & Gamble Company Method and system for assessing health condition
ES2968004T3 (es) 2014-07-30 2024-05-06 Harvard College Construcción de bibliotecas de sondas
CN104263723B (zh) * 2014-09-15 2017-06-06 南京医科大学 一种与原发性肺癌辅助诊断相关的低频高外显性遗传标志物及其应用
WO2016094330A2 (en) * 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
JP6857185B2 (ja) * 2015-09-11 2021-04-14 アプタマー サイエンス インコーポレイテッドAptamer Sciences Inc. 非小細胞肺癌診断用タンパク質バイオマーカーパネル及びこれを用いた非小細胞肺癌診断方法
JP6688884B2 (ja) * 2015-11-05 2020-04-28 ビージーアイ シェンチェン 肺腺癌を検出するためのバイオマーカー及びその使用
US10731166B2 (en) * 2016-03-18 2020-08-04 Caris Science, Inc. Oligonucleotide probes and uses thereof
KR101853118B1 (ko) * 2016-09-02 2018-04-30 주식회사 바이오인프라생명과학 피험체의 폐암 진단을 위한 복합 바이오마커군, 이를 이용하는 폐암 진단용 키트, 복합 바이오마커군의 정보를 이용하는 방법 및 이를 수행하는 컴퓨팅 시스템
EP3539036A4 (en) * 2016-11-08 2020-06-17 President and Fellows of Harvard College MATRIX AND DELETE
CN110402394B (zh) * 2017-03-01 2024-04-26 豪夫迈·罗氏有限公司 用于将关于分析物的存在的生物样品进行分类的系统和方法
WO2018218150A1 (en) 2017-05-26 2018-11-29 President And Fellows Of Harvard College Systems and methods for high-throughput image-based screening
CN109116023B (zh) * 2018-06-14 2021-06-04 郑州大学第一附属医院 一种肺癌标志物抗-mmp12自身抗体及其应用
CN109470859A (zh) * 2018-11-04 2019-03-15 华东医院 一种外泌体蛋白作为鉴别肺结节良恶性标志物及其应用
CN113366116A (zh) 2018-12-13 2021-09-07 哈佛学院院长及董事 用于merfish和其他应用的扩增方法和系统
EP3671210A1 (en) * 2018-12-21 2020-06-24 Biosystems International KFT Lung cancer protein epitomic biomarkers
EP3924974A4 (en) * 2019-02-15 2022-11-16 Biodesix, Inc. PREDICTIVE TEST FOR THE IDENTIFICATION OF PATIENTS WITH EARLY STAGE NSCLC AND AT HIGH RISK OF RECIDENCE AFTER SURGICAL PROCEDURE
CN110473167B (zh) * 2019-07-09 2022-06-17 哈尔滨工程大学 一种基于深度学习的尿沉渣图像识别系统及方法
CN112892619B (zh) * 2019-12-04 2022-07-15 香港城市大学深圳研究院 弧形边缘截面的pdms母模、微流控阀和芯片及其制备
CN116670497A (zh) * 2020-11-11 2023-08-29 乔治·梅森研究基金会股份有限公司 激光捕获显微切割可视化化学物质
KR102613772B1 (ko) * 2021-02-02 2023-12-14 제노마인(주) 폐암 혈액 바이오마커의 검출 방법 및 키트
WO2025144995A1 (en) * 2023-12-29 2025-07-03 Novelna Inc. Lung cancer detection proteins and methods of use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3316600A (en) * 1999-02-22 2000-09-21 Torben F. Orntoft Gene expression in bladder tumors
US6596503B1 (en) 2000-08-18 2003-07-22 East Carolina University Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
ATE483979T1 (de) * 2004-08-10 2010-10-15 Oncotherapy Science Inc Gen anln in verbindung mit nicht-kleinzelligem lungenkrebs und seine wechselwirkungen mit rhoa
EP2295570A1 (en) * 2005-07-27 2011-03-16 Oncotherapy Science, Inc. Method of diagnosing small cell lung cancer
WO2007015947A2 (en) * 2005-07-29 2007-02-08 Bayer Healthcare Llc Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
US8445198B2 (en) * 2005-12-01 2013-05-21 Medical Prognosis Institute Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
US8014957B2 (en) * 2005-12-15 2011-09-06 Fred Hutchinson Cancer Research Center Genes associated with progression and response in chronic myeloid leukemia and uses thereof
EP2090665A2 (en) * 2006-10-20 2009-08-19 Exiqon A/S Novel human microRNAs associated with cancer
GB0803192D0 (en) * 2008-02-22 2008-04-02 Mubio Products Bv SCLC biomarker panel
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
SI2340506T1 (sl) * 2008-09-09 2016-02-29 Somalogic, Inc. Biomarkerji za pljučni rak in njihove uporabe
US8541170B2 (en) 2008-11-17 2013-09-24 Veracyte, Inc. Methods and compositions of molecular profiling for disease diagnostics
CN102308212A (zh) 2008-12-04 2012-01-04 加利福尼亚大学董事会 用于确定前列腺癌诊断和预后的材料和方法
WO2011100472A1 (en) * 2010-02-10 2011-08-18 The Regents Of The University Of California Salivary transcriptomic and proteomic biomarkers for breast cancer detection
KR20130056855A (ko) 2010-03-01 2013-05-30 카리스 라이프 사이언스 룩셈부르크 홀딩스 치료진단용 생물학적 지표들
KR20130043104A (ko) 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 질병용 순환 생물학적 지표들

Also Published As

Publication number Publication date
AU2011378427B8 (en) 2015-08-27
EP2771692A4 (en) 2015-08-26
KR20140082840A (ko) 2014-07-02
CN106168624A (zh) 2016-11-30
IL252163A0 (en) 2017-07-31
CA2847188C (en) 2020-02-18
CA3064363C (en) 2022-05-17
CN103890586B (zh) 2016-06-29
BR112014006432B1 (pt) 2021-04-06
IL231426A0 (en) 2014-04-30
MX2014004860A (es) 2014-05-27
AU2011378427A1 (en) 2013-05-16
CA3006793C (en) 2020-02-18
WO2013062515A3 (en) 2014-04-17
IN2014CN01787A (enExample) 2015-05-29
SG11201400375SA (en) 2014-04-28
EP2771692A2 (en) 2014-09-03
CA3064363A1 (en) 2013-05-02
JP2015501154A (ja) 2015-01-15
BR112014006432A2 (pt) 2017-04-04
AU2011378427A8 (en) 2015-08-27
ZA201401476B (en) 2016-06-29
CA2847188A1 (en) 2013-05-02
ES2674318T3 (es) 2018-06-28
BR112014006432B8 (pt) 2022-10-25
WO2013062515A2 (en) 2013-05-02
CA3006793A1 (en) 2013-05-02
CN103890586A (zh) 2014-06-25
IL231426A (en) 2017-06-29
EP2771692B1 (en) 2018-04-18
JP5986638B2 (ja) 2016-09-06
NZ621733A (en) 2015-05-29
KR101921945B1 (ko) 2018-11-26
AU2011378427B2 (en) 2015-07-16
CN106168624B (zh) 2018-03-13

Similar Documents

Publication Publication Date Title
MX355416B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
MX340453B (es) Biomarcadores para cancer de pulmon.
MX355020B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
EA201590027A1 (ru) Способы детекции заболеваний или состояний
AR090973A1 (es) Anticuerpos utiles para el diagnostico del cancer
HK1214652A1 (zh) 用於检测胰腺癌的方法和组合物
WO2013022786A3 (en) Microrna biomarkers
TN2013000464A1 (en) Biomarkers for hedgehog inhibitor therapy
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
EP4060048A3 (en) Non-invasive diagnostic method for diagnosing bladder cancer
WO2013066369A3 (en) Methods for detecting graft-versus-host disease
WO2012021887A3 (en) Biomarkers for the early detection of breast cancer
EA201690213A1 (ru) Композиции и способ лечения связанных с комплементом состояний
MX2013003077A (es) Diagnostico de cancer de mama.
ITRM20120383A1 (it) Metodo e kit per la rivelazione di anticorpi.
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
ECSP11011376A (es) Dispositivo y procedimiento para la verificación y para el análisis cuantitativo de analitos, particularmente de micotoxinas
MX358474B (es) Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson.
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
PT2734636T (pt) Biomarcadores micro-arn para identificar o risco de e/ou para diagnosticar tumor do pulmão
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
MX360479B (es) Anticuerpos contra microbioma, factores de estres y marcadores de mastocitos como marcadores de diagnostico para ibs.
WO2013124738A3 (en) Methods and biomarkers for detection and prognosis of cervical cancer
NZ712023A (en) Caix stratification based cancer treatment
WO2013044187A3 (en) Detecting ovarian cancer

Legal Events

Date Code Title Description
FG Grant or registration